RYAH Group

Our new partnership with Medical Kiwi further expands our global clinical and distribution network for plant-based medicine and digital care.  It presents an opportunity for both parties to drive innovation and to deliver cutting edge plant-based medical solutions to New Zealand.”

– Gregory Wagner, CEO RYAH Group.

Medical Kiwi’s Distribution Agreement with USA company, RYAH Group secures future sales. Medical Kiwi will distribute the RYAH Smart Inhaler and cloud based data analytics platform in New Zealand.

The agreement will enable RYAH’s suite of connected IoT devices and cloud-based data analytics to be connected with Medical Kiwi’s cultivated medical cannabis formulations adn patient network for pre-clinical and clinical trial settings as well as medical patient care in New Zealand.

 

About RYAH Group
RYAH Group, is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and Licensed Processors (LPs) to monitor and manage formulation effects on patient and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle.

Benefits for Medical Kiwi:

  • Securing future sales helps Medical Kiwi to plan our production facilities with certainty.
  • Obtaining cutting edge medical technology for our exclusive use in New Zealand helps ensure we’re not only leaders in the medical cannabis industry in New Zealand, but also globally.

Want to know more?